Serving Overlooked PatientsSM
Azurity Pharmaceuticals is a privately held company committed to delivering innovative, high-quality medicines for overlooked patients. Azurity’s global footprint is over 50 countries, with a diversified portfolio of 50+ medicines spanning 10 dosage forms and 10 key therapeutic areas. Powered by its Next-Gen Commercial Model, Azurity leverages data, analytics, and AI-driven digital tools to enhance market reach and stakeholder engagement. Our medicines have benefited millions of people.
PRODUCT ANNOUNCEMENT
NOW AVAILABLE

Click for Full Prescribing Information,
including Indication, BOXED WARNING, and Important Safety Information.
PRODUCT ANNOUNCEMENT

Click for Full Prescribing Information, including Indication and Additional Safety Information.
PRODUCT ANNOUNCEMENT
NOW AVAILABLE

Click for Full Prescribing Information, including Indication, BOXED WARNING, and Important Safety Information.
PRODUCT ANNOUNCEMENT

Click for Full Prescribing Information, including Indication and Additional Safety Information.
OUR PRODUCTS
Azurity offers an ever expanding portfolio of products targeting key therapeutic areas.
News & Events
Azurity Pharmaceuticals Expands Portfolio with CONTRAVE® and Related Assets
WOBURN, Mass. — June 30, 2026 — Azurity Pharmaceuticals, a global pharmaceutical company dedicated to redefining medicine for the real world, today announced the expansion of its portfolio through the acquisition of CONTRAVE® and related assets, expanding the company’s presence in obesity and chronic weight management.
Azurity Pharmaceuticals Announces FDA Approval of Aprepitant Injectable Emulsion, Expanding Access to Critical Supportive Oncology Care
WOBURN, MA – June 25, 2026 – Azurity Pharmaceuticals, a global pharmaceutical company dedicated to redefining medicine for the real world, today announced that the U.S. Food and Drug Administration (FDA) has approved Aprepitant Injectable Emulsion, a practical, administration-friendly treatment option aimed at making the patient experience more manageable.